Ahmad Faramarzi

Cost per DALY averted in low, middle- and high-income countries: evidence from the global burden of disease study to estimate the cost-effectiveness thresholds

Rajabali Daroudi, Ali Akbari Sari, Azin Nahvijou et al. · Cost Effectiveness and Resource Allocation · 2021 · 89 citations · Full text

Pharmacy, Pharmacoeconomics, Population Health Sciences +17

The lost productivity cost of absenteeism due to COVID-19 in health care workers in Iran: a case study in the hospitals of Mashhad University of Medical Sciences

Ahmad Faramarzi, Javad Javan‐Noughabi, Seyed Saeed Tabatabaee et al. · BMC Health Services Research · 2021 · 62 citations · Full text

Social Sciences, Health Sciences, Human Resource Management +16

Trends in burden of chronic obstructive pulmonary disease in Iran, 1995–2015: findings from the global burden of disease study

Seyed Yaser Hashemi, Victoria Momenabadi, Ahmad Faramarzi et al. · Archives of Public Health · 2020 · 47 citations · Full text

Public Health, Health Sciences, Epidemiology +15

Identification determinant factors on willingness to pay for health services in Iran

Javad Javan‐Noughabi, Zahra Kavosi, Ahmad Faramarzi et al. · Health Economics Review · 2017 · 31 citations · Full text

Social Sciences, Economics, Health Behavior +14

Health care expenditure in the Islamic Republic of Iran versus other high spending countries

Bahman Khosravi, Shahin Soltani, Javad Javan‐Noughabi et al. · Medical Journal of the Islamic Republic of Iran · 2017 · 24 citations · Full text

Health Professions, Health Administration, Health Care Financing +7